Soleno Therapeutics, Inc. (SLNO) Stock Price Today & Analysis
SLNO
Valuation
Market cap$2.28B
Price-to-sales ratio22.83
Price-to-book value4.55
Price-earnings ratio-28.70
Return on Equity-26.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-1.85
Income Statement
Average volume1,580,325
EBITDA$-71.40M
1 year high (52w)$90.32
1 year low (52w)$39.43
Dividend
Dividend yield0.00%
Solvency
Debt-to-equity ratioN/A
About Soleno Therapeutics, Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
FAQ
You can easily purchase Soleno Therapeutics, Inc. (SLNO) shares through the Gotrade app. Simply download the app, set up your account, fund it, and then search for the 'SLNO' ticker to begin your investment journey.
At Gotrade, you can kickstart your investment in Soleno Therapeutics, Inc. with as little as $1.
Absolutely. Brokerage services on Gotrade Indonesia are provided by PT Valbury Asia Futures, a licensed futures and commodities broker registered with and supervised by the Indonesian Financial Services Authority (OJK).
Yes. Gotrade provides access to U.S. stocks from Indonesia through fully backed shares. This is facilitated through a cross-border order routing scheme for foreign stock derivative contracts (PALN), in accordance with regulations from Bappebti (the Commodity Futures Trading Regulatory Agency).
When you trade, you enter into a contract with PT Valbury Asia Futures (Valbury), a Bappebti-registered broker in Indonesia. Valbury, in turn, fully backs its contracts 1-for-1 with Alpaca Securities LLC, a FINRA-licensed broker-dealer in the United States. For every share (or fraction thereof) you hold on Gotrade, a corresponding share is held by Valbury in a separate, segregated brokerage account at Alpaca Securities LLC.
